tiprankstipranks
Pediatrix Medical Group, Inc. (MX:MD)
NYSE:MD
Mexico Market
MD
Pediatrix Medical Group
RESEARCH TOOLSreports

Pediatrix Medical Group (MD) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MD Analyst Ratings

Hold
4Ratings
Hold
1 Buy
3 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Pediatrix
Medical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MD Stock 12 Month Forecast

Average Price Target

$444.57
▼(-1.75% Downside)
Based on 4 Wall Street analysts offering 12 month price targets for Pediatrix Medical Group in the last 3 months. The average price target is $444.57 with a high forecast of $488.15 and a low forecast of $383.55. The average price target represents a -1.75% change from the last price of $452.49.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"239":"$239","364":"$364","489":"$489","301.5":"$301.5","426.5":"$426.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":488.15355904,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$488.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":444.56841984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$444.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":383.54922496,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$383.55</span>\n  </div></div>","useHTML":true}}],"tickPositions":[239,301.5,364,426.5,489],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,371.6,380.56565838769234,389.53131677538465,398.49697516307697,407.4626335507692,416.42829193846154,425.39395032615386,434.35960871384617,443.3252671015385,452.29092548923074,461.25658387692306,470.2222422646154,479.1879006523077,{"y":488.15355904,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,371.6,377.2129553723077,382.8259107446154,388.4388661169231,394.0518214892308,399.6647768615385,405.27773223384617,410.89068760615385,416.5036429784615,422.1165983507692,427.72955372307695,433.3425090953846,438.9554644676923,{"y":444.56841984,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,371.6,372.51917115076924,373.43834230153846,374.3575134523077,375.27668460307694,376.19585575384616,377.1150269046154,378.03419805538465,378.95336920615387,379.8725403569231,380.7917115076923,381.71088265846157,382.6300538092308,{"y":383.54922496,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":288,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":316.35,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":323,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":323,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.45,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":323,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":338.14,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":338.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":404.57,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$488.15Average Price Target$444.57Lowest Price Target$383.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:MD
David S Macdonald
Truist Financial
Truist Financial
$400.98→$488.15
Hold
7.88%
Upside
Reiterated
07/14/26
Pediatrix Medical price target raised to $28 from $23 at TruistPediatrix Medical price target raised to $28 from $23 at Truist
Mizuho Securities Analyst forecast on MX:MD
Ann Hynes
Mizuho Securities
Mizuho Securities
$418.42→$470.72
Hold
4.03%
Upside
Reiterated
07/13/26
Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (NYSE: MD) and Travere Therapeutics (NASDAQ: TVTX)
UBS Analyst forecast on MX:MD
A.J. Rice
UBS
UBS
$383.55→$435.85
Hold
-3.68%
Downside
Reiterated
05/12/26
Pediatrix Medical price target raised to $25 from $22 at UBSPediatrix Medical price target raised to $25 from $22 at UBS
William Blair Analyst forecast on MX:MD
Ryan Daniels
William Blair
William Blair
$383.55
Buy
-15.24%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pediatrix Medical Group (NYSE: MD)
Jefferies Analyst forecast on MX:MD
Jack Slevin
Jefferies
Jefferies
$418.42→$470.72
Buy
4.03%
Upside
Reiterated
04/20/26
Pediatrix Medical price target raised to $27 from $24 at JefferiesPediatrix Medical price target raised to $27 from $24 at Jefferies
Deutsche Bank Analyst forecast on MX:MD
Pito Chickering
Deutsche Bank
Deutsche Bank
$366.12→$331.25
Hold
-26.79%
Downside
Reiterated
02/20/26
Pediatrix Medical price target lowered to $19 from $21 at Deutsche BankPediatrix Medical price target lowered to $19 from $21 at Deutsche Bank
Leerink Partners Analyst forecast on MX:MD
Whit Mayo
Leerink Partners
Leerink Partners
$296.38
Hold
-34.50%
Downside
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:MD
David S Macdonald
Truist Financial
Truist Financial
$400.98→$488.15
Hold
7.88%
Upside
Reiterated
07/14/26
Pediatrix Medical price target raised to $28 from $23 at TruistPediatrix Medical price target raised to $28 from $23 at Truist
Mizuho Securities Analyst forecast on MX:MD
Ann Hynes
Mizuho Securities
Mizuho Securities
$418.42→$470.72
Hold
4.03%
Upside
Reiterated
07/13/26
Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (NYSE: MD) and Travere Therapeutics (NASDAQ: TVTX)
UBS Analyst forecast on MX:MD
A.J. Rice
UBS
UBS
$383.55→$435.85
Hold
-3.68%
Downside
Reiterated
05/12/26
Pediatrix Medical price target raised to $25 from $22 at UBSPediatrix Medical price target raised to $25 from $22 at UBS
William Blair Analyst forecast on MX:MD
Ryan Daniels
William Blair
William Blair
$383.55
Buy
-15.24%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pediatrix Medical Group (NYSE: MD)
Jefferies Analyst forecast on MX:MD
Jack Slevin
Jefferies
Jefferies
$418.42→$470.72
Buy
4.03%
Upside
Reiterated
04/20/26
Pediatrix Medical price target raised to $27 from $24 at JefferiesPediatrix Medical price target raised to $27 from $24 at Jefferies
Deutsche Bank Analyst forecast on MX:MD
Pito Chickering
Deutsche Bank
Deutsche Bank
$366.12→$331.25
Hold
-26.79%
Downside
Reiterated
02/20/26
Pediatrix Medical price target lowered to $19 from $21 at Deutsche BankPediatrix Medical price target lowered to $19 from $21 at Deutsche Bank
Leerink Partners Analyst forecast on MX:MD
Whit Mayo
Leerink Partners
Leerink Partners
$296.38
Hold
-34.50%
Downside
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pediatrix Medical Group

3 Months
OpenAI Medical - Care FacilitiesTipRanks - OpenAI
Success Rate
2/3 ratings generated profit
67%
Average Return
+15.13%
Copying OpenAI Medical - Care Facilities's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.13% per trade.
1 Year
Jack SlevinJefferies
Success Rate
4/4 ratings generated profit
100%
Average Return
+26.75%
Copying Jack Slevin's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +26.75% per trade.
2 Years
Jack SlevinJefferies
Success Rate
4/4 ratings generated profit
100%
Average Return
+66.90%
Copying Jack Slevin's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +66.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MD Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
1
2
2
2
1
Hold
4
5
4
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
6
6
6
In the current month, MD has received 1 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. MD average Analyst price target in the past 3 months is 444.57.
Each month's total comprises the sum of three months' worth of ratings.

MD Financial Forecast

MD Earnings Forecast

Next quarter’s earnings estimate for MD is $10.30 with a range of $9.87 to $10.81. The previous quarter’s EPS was $7.67. MD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.79% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
Next quarter’s earnings estimate for MD is $10.30 with a range of $9.87 to $10.81. The previous quarter’s EPS was $7.67. MD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.79% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.

MD Sales Forecast

Next quarter’s sales forecast for MD is $8.34B with a range of $8.19B to $8.42B. The previous quarter’s sales results were $8.30B. MD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.83% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
Next quarter’s sales forecast for MD is $8.34B with a range of $8.19B to $8.42B. The previous quarter’s sales results were $8.30B. MD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.83% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.

MD Stock Forecast FAQ

What is MX:MD’s average 12-month price target, according to analysts?
Based on analyst ratings, Pediatrix Medical Group, Inc.’s 12-month average price target is 444.57.
    What is MX:MD’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:MD, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Pediatrix Medical Group, Inc. a Buy, Sell or Hold?
        Pediatrix Medical Group, Inc. has a consensus rating of Hold, which is based on 1 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Pediatrix Medical Group, Inc.’s share price target?
          The average share price target for Pediatrix Medical Group, Inc. is 444.57. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $488.15 ,and the lowest forecast is $383.55. The average share price target represents -1.75% Decrease from the current price of $452.49.
            What do analysts say about Pediatrix Medical Group, Inc.?
            Pediatrix Medical Group, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
              How can I buy shares of Pediatrix Medical Group, Inc.?
              To buy shares of MX:MD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.